RegCell, a Japanese-founded biotechnology company, has announced the closing of an oversubscribed seed round and its transition to a USA-based company, based in Emeryville, California.

Read more here

Previous
RegCell opens up cell therapy shop in California with $45M in funding
Next
Finance Watch: Venture Capital Mega-Rounds Attempt A Rebound In March